IGF2BP1 and gastric cancer: Furthermore, overexpression of IGF2BP1 significantly promoted GC cell survival and counteracted cisplatin‐induced apoptosis, but knockdown of ABL in IGF2BP1‐overexpressing GC cells using specific siRNAs markedly suppressed these effects (Figure S5N–P, Supporting Information).